3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
MMTC M Header 

Cambridge Healthtech Institute’s Fifth Annual

Circulating Tumor Cells

Future of Cancer Management

February 16-18, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd Annual Molecular Medicine Tri-Conference


Circulating biomarkers continue to dominate cancer research by detecting the elusive signature in blood, serum or plasma. Isolation and characterization of circulating tumor cells and cell-free DNA enable the precise diagnosis and monitoring of cancer but significant challenges remain in validating methods for clinical use. This conference will showcase advances in technology and clinical applications and ultimately decide which will be the most robust technologies for personalized cancer care.

Scientific Advisory Board

Stefanie Jeffrey, M.D., John and Marva Warnock Professor, Surgery; Chief, Surgical Oncology Research, Stanford University School of Medicine

Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University, Medical Center Hamburg-Eppendorf

Steven A. Soper, Ph.D., William H. Pryor Emeritus Professor, Biomedical Engineering and Chemistry, University of North Carolina, Chapel Hill

Avraham Rasooly, Ph.D., Health Scientist Administrator, Cancer Diagnosis Program, National Cancer Institute


CTC: Current Clinical Utility and Future Prospects

Daniel F. Hayes, M.D., F.A.S.C.O., Stuart B. Padnos Professor, Breast Cancer Research; Clinical Director, Breast Oncology Program, Internal Medicine and Hematology Oncology, University of Michigan Comprehensive Cancer Center

Talk Title to be Announced

Daniel Danila, M.D., Medical Oncology Fellow, Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering


Circulating Tumor Cells in Lung Cancer, Biomarkers, Biology, and Mouse Models

Caroline Dive, BPharm, Ph.D., Professor & Senior Group Leader, Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute

Novel Approaches to Enable Molecular Characterization of CTCs

Nikolas H. Stoecklein, M.D., Professor, General Visceral, and Pediatric Surgery, University Hospital of the Heinrich-Heine, University of Düsseldorf

Deep Sequencing of Circulating Tumor Cells as a Window into Disseminated Cancer

Jens Lohr, M.D., Ph.D., Instructor in Medicine, Medical Oncology, Cancer Program, Dana-Farber Cancer Institute; Broad Institute

Recovery and Analysis of FFPE Derived Pure Tumor Cells Using the DEPArray System: Enabling Molecular Profiling and NGS Applications

Farideh Z. Bischoff, Ph.D., Executive Director Scientific Affairs, Silicon Biosystems


Platforms for CTC Isolation and Analysis

Z. Hugh Fan, Ph.D., Professor, Mechanical and Aerospace Engineering, University of Florida


Jorge S. Reis-Filho, M.D., Ph.D., FRCPath, Experimental Pathologist, Pathology, Memorial Sloan Kettering

Circulating Exosomes

Raghu Kalluri, M.D., Ph.D., Professor, Cancer Biology; Chair, Cancer Biology, MD Anderson

Microfluidic Isolation of Microvesicles and Circulating Tumor Cells from Cancer Patients

Shannon L. Stott, Ph.D., Assistant Professor, Medicine, Massachusetts General Hospital and Harvard Medical School

Luncheon Presentation


Drug-Induced Damage of Genomic DNA Harvested from Circulating Tumor Cell Sub-Populations

Steven A. Soper, Ph.D., William H. Pryor Emeritus Professor, Biomedical Engineering and Chemistry, University of North Carolina, Chapel Hill

Single-Cell Analysis

Daniel T. Chiu, Ph.D., A. Bruce Montgomery Professor, Chemistry & Bioengineering, University of Washington

Single-Cell Analysis Using Drop Based Microfluidics

David A. Weitz, Ph.D., Mallinckrodt Professor, Physics, School of Engineering & Applied Sciences, Harvard University


Vortex Technology for CTC Collection and Automated Image Cytometry for CTC Detection

Dino Di Carlo, Ph.D., Associate Professor, Bioengineering, California NanoSystems Institute, Jonsson Comprehensive Cancer Center, University of California, Los Angeles

Nanoroughened Surfaces for Efficient Capture of Circulating Tumor Cells

Jianping Fu, Ph.D., Assistant Professor, Mechanical Engineering, University of Michigan

Geometrically Enhanced Differential Immunocapture (GEDI)

Brian J. Kirby, Ph.D., Associate Professor, Mechanical and Aerospace Engineering, Cornell University


New Results on CTCs in Glioma Patients and Next-Generation Sequencing Data

Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf

Clinical Applications of the Genetic Variation of Circulating Tumor Cells

Sunney Xie, Ph.D., Mallinckrodt Professor, Chemistry and Chemical Biology, Harvard University

Targeting Microtentacles on Circulating Tumor Cells to Reduce Metastasis

Stuart S. Martin, Ph.D., Associate Professor, Physiology, Greenebaum Cancer Center, University of Maryland School of Medicine


CTCs in Mouse Models

Jen Jen Yeh, M.D., Associate Professor, Surgery and Pharmacology, UNC Chapel Hill Lineberger Comprehensive Cancer Center

Challenges and Opportunities in the Use of CTCs for Companion Diagnostic Development

Elizabeth Punnoose, Ph.D., Senior Scientist, Oncology Biomarker Development, Genentech, Inc.

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5464
E:  clingham@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com 



  2015 Plenary Sessions 

2015 MMTC Prelim Agenda 

Premier Sponsors:



Jackson Laboratory - small logo 

Leica Biosystems